Dihydroergocryptine in the management of senile psycho-organic syndrome
L. et al. Scarzella
Bok Engelsk
| Omfang | 10 s.
|
|---|---|
| Utgave | Kopi
|
| Opplysninger | aSummary: A double-blind, placebo-controlled, randomized study is described of an assessment of the efficacy and relative safety of the ergot alkaloid, dihydroergocryptine, on 52 patients with mild organic brain syndrome over a period of three months using a series of neurophysiological tests. The results indicated that short-term treatment with the alkaloid improved memory impairment. the side-effects were mild and transient in both the dihydroergocryptine and placebo groups and there were no alterations in both the dihydroergocryptine and placebo groups and there were no alterations in blood chemistry.
|
| Emner |
